Other top stories

Growing Interest in Cannabinoids for PTSD Yields Mixed Results

October 16, 2024

Esketamine Nasal Spray Offers Help for Treatment-Resistant Depression

October 15, 2024

Disaster Surge Highlights Need For Better Mental Health Support

October 14, 2024

Weekly Mind Reader: What Do OCD and Pica Have In Common?

October 11, 2024

Case Study Ties Psilocybin to Serotonin Toxicity When Used with Antidepressants

October 9, 2024

Even Mild COVID Cases Leave Lasting Brain Changes in Young Adults

October 8, 2024

Other stories

Early Trauma Linked to More Pain and Loneliness at Life’s End

October 7, 2024

Anxiety Grips Voters as Election Day Looms

October 4, 2024

Weekly Mind Reader: The Digital Era’s Impact on Mental Health

October 4, 2024

The History of Dopaminergic Blockade in Schizophrenia

October 4, 2024

Beyond Dopamine: Evaluating the Pipeline for Schizophrenia

October 4, 2024

Xanomeline-Trospium and Iclepertin Show Promise in Managing Cognitive Impairment in Schizophrenia

October 4, 2024

Consensus Report on XT Use in Practice

Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe